irasia.com - Investor Relations Asia Pacific
HOME

WuXi Biologics (Cayman) Inc.
(Incorporated in the Cayman Islands with limited liability)

Press Releases       


Please download the latest "Acrobat Reader" to view the PDF.

  • 2022-March-22
  • WuXi Biologics Achieved Record Growth and Profitability in 2021, Banner Year for Commercial Manufacturing, Revenue Increased by 83.3% Y-o-Y to RMB10,290.1 Million, Gross Profit Increased by 90.6% Y-o-Y to RMB4,828.9 Million, Net Profit Grew by 107.3% Y-o-Y to RMB3,508.6 Million, Adjusted Net Profit Rose by 100.3% to RMB3,435.9 Million, Total Backlog Grew 20.1% to US$13,597 Million (in PDF)
  • 2021
  • 2021 Press Releases
  • 2020
  • 2020 Press Releases
  • 2019
  • 2019 Press Releases
  • 2018
  • 2018 Press Releases
  • 2017
  • 2017 Press Releases


  • Company's Index
  • irasia.com

  • About irasia.com   |   Terms of Use   |   Privacy Policy Statement   |   Disclaimer
    © Copyright 1996-2024 irasia.com Ltd. All rights reserved.
    DISCLAIMER:
    irasia.com Ltd. makes no guarantee as to the accuracy or completeness of any information provided on this website. Under no circumstances shall irasia.com Ltd. be liable for damages resulting from the use of the information provided on this website.
    Cookie Policy

    This website uses cookies. Please refer to our Cookie Notice and Privacy Notice for further information. By continuing to use this website, you agree to our use of cookies.

    Close